- Home
- ABVX vs CLFD Comparison
ABVX vs CLFD Comparison
Compare ABVX & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- CLFD
- Stock Information
- Founded
- ABVX 2013
- CLFD 1979
- Country
- ABVX France
- CLFD United States
- Employees
- ABVX N/A
- CLFD N/A
- Industry
- ABVX
- CLFD Telecommunications Equipment
- Sector
- ABVX
- CLFD Utilities
- Exchange
- ABVX Nasdaq
- CLFD Nasdaq
- Market Cap
- ABVX 378.7M
- CLFD 426.1M
- IPO Year
- ABVX N/A
- CLFD N/A
- Fundamental
- Price
- ABVX $6.40
- CLFD $26.51
- Analyst Decision
- ABVX Buy
- CLFD Strong Buy
- Analyst Count
- ABVX 8
- CLFD 3
- Target Price
- ABVX $34.63
- CLFD $46.67
- AVG Volume (30 Days)
- ABVX 165.7K
- CLFD 107.7K
- Earning Date
- ABVX 03-24-2025
- CLFD 05-01-2025
- Dividend Yield
- ABVX N/A
- CLFD N/A
- EPS Growth
- ABVX N/A
- CLFD N/A
- EPS
- ABVX N/A
- CLFD N/A
- Revenue
- ABVX $11,172,999.00
- CLFD $167,951,000.00
- Revenue This Year
- ABVX $371.31
- CLFD $8.64
- Revenue Next Year
- ABVX N/A
- CLFD $16.53
- P/E Ratio
- ABVX N/A
- CLFD N/A
- Revenue Growth
- ABVX 135.94
- CLFD N/A
- 52 Week Low
- ABVX $4.77
- CLFD $23.78
- 52 Week High
- ABVX $16.63
- CLFD $44.83
- Technical
- Relative Strength Index (RSI)
- ABVX 52.21
- CLFD 38.26
- Support Level
- ABVX $5.89
- CLFD $26.03
- Resistance Level
- ABVX $6.71
- CLFD $27.19
- Average True Range (ATR)
- ABVX 0.60
- CLFD 1.48
- MACD
- ABVX 0.08
- CLFD 0.01
- Stochastic Oscillator
- ABVX 84.02
- CLFD 44.75
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
About CLFD Clearfield Inc.
Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a range of products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has a global presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.